The employee cooperation and change negotiations related to the organizational restructuring of FVR – Finnish Vaccine Research have been completed. The company started the negotiations in January to strengthen its future operations and growth potential in the global competitive market for vaccine research.

As a result of the negotiations, the company will open a new, larger site in Helsinki by combining the current two small clinics. The new clinic will open on February 1, 2025. The company will also proceed with a phased closure of its clinic in Pori by the end of 2024. In addition, FVR will improve its operational efficiency by revising its organizational model, roles and responsibilities.

As a result of the decisions, the terms of the employment contracts of twenty employees will be changed or they will be offered a new position. The employment relationship of maximum of nine people will be terminated or ended at the end of a fixed-term contract. If, during the employees’ dismissal period or employer’s readmission obligation, there is a need for replacement recruitments, or the new positions offered are not accepted, the final personnel impacts of this change may differ from those mentioned above.

Further information:
Marikka Nevamäki
Chief Communications and Marketing Officer
marikka.nevamaki@fvr.fi
+358 40 417 96 84